Wordt geladen...
Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials
As the most important viral cause of severe respiratory disease in infants and increasing recognition as important in the elderly and immunocompromised, respiratory syncytial virus (RSV) is responsible for a massive health burden worldwide. Prophylactic antibodies were successfully developed against...
Bewaard in:
Gepubliceerd in: | Influenza Other Respir Viruses |
---|---|
Hoofdauteurs: | , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
BlackWell Publishing Ltd
2015
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4474493/ https://ncbi.nlm.nih.gov/pubmed/25847510 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/irv.12313 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|